Mereo BioPharma Group plc (MREO)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.3602+$0.0227 (+6.73%) on the dayAs of the close; data may be delayed.
MREO price, last 12 months
Key stats
- Previous close
- $0.3375
- Open
- $0.3400
- Day range
- $0.3273 – $0.3722
- 52-week range
- $0.2000 – $2.37
- Volume
- 2.1M
- Avg volume (20 days)
- 1.8M
- Market cap
- $59.1M
Performance
1W+18.9%
1M+29.6%
3M+21.4%
6M+6.3%
YTD−13.6%
1Y−80.0%
vs S&P 500, 1Y−96.8 pts
Technicals and fundamentals
About Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $59.1M